在世界肝炎日即将来临之际,中国多地启动了旨在消除病毒性肝炎危害的项目试点,探索出多样化的创新模式,并建立了“应筛尽筛、应诊尽诊、应治尽治、应管尽管”的一体化协作机制。这一举措旨在加速肝炎的防控进程,减轻肝炎对人类健康的威胁。

肝炎防治工作面临着三大挑战:筛查率低、诊断率低、治疗率低。由于肝炎感染者基数庞大,疾病负担沉重,中国肝炎防治工作任重道远。今年的世界肝炎日主题为“消除肝炎,积极行动”,旨在提升公众对病毒性肝炎防治的意识,号召全社会积极参与,共同减少新发感染,有效发现和治疗患者。

临床、疾控、基金会、公益组织、企业等各界专家和代表汇聚一堂,共同分享中国肝炎防治工作的探索和成果,呼吁全社会的公众和肝炎患者积极行动起来,共创一个没有肝炎的未来。

中国已具备消除肝炎的条件。通过不断推动政策与立法、制定和更新防治指南与共识、加速创新药物上市、诊疗技术的革新以及公众健康教育等措施,病毒性肝炎感染人数正在逐步下降。筛查作为消除肝炎工作中的关键环节,海南儋州、广东均安镇等地作为试点,通过“应筛尽筛”策略,为无感染人群提供免费接种疫苗服务,同时对确诊患者实施治疗和健康管理。

尽早诊断是规范治疗的前提。上海交通大学医学院附属瑞金医院感染科主任谢青教授强调,乙肝患者在接受筛查后应及时进行“应诊尽诊”,通过灵敏度更高的乙肝病毒DNA检测方法,诊断出低病毒载量的人群,有助于扩大治疗范围。当前,乙肝治疗理念已升级为“全治”策略,通过及时治疗,降低肝硬化和肝癌的发生风险。

随着丙肝治疗进入直接抗病毒药物(DAA)的泛基因时代,绝大多数丙肝患者通过连续服药3个月即可实现治愈。这一进展为丙肝患者带来了希望,减少了疾病的长期影响。

综上所述,中国多地建一体化协作机制、多措并举消除病毒性肝炎的工作展现了国家对肝炎防治的高度重视和创新实践。通过全社会的共同努力,中国正朝着消除肝炎的目标稳步前进,为全球肝炎防治工作树立了典范。

英语如下:

News Title: “Multiple Chinese Regions Launch Hepatitis Eradication Projects, Establishing an Integrated Collaboration Mechanism”

Keywords: Hepatitis Prevention and Control, Integrated Collaboration, Eradication Objective

Content: As World Hepatitis Day approaches, several regions in China have initiated pilot projects aimed at eliminating the threat of viral hepatitis, exploring diverse innovative models, and establishing an integrated collaboration mechanism that ensures “screening for all, diagnosis for all, treatment for all, and management for all.” This initiative is geared towards accelerating the control and prevention of hepatitis, mitigating its impact on human health.

The work of hepatitis prevention and control faces three major challenges: low screening rates, low diagnosis rates, and low treatment rates. Given the vast number of hepatitis-infected individuals and the heavy disease burden, the work of hepatitis prevention and control in China is far from over. This year’s theme for World Hepatitis Day is “Eliminate Hepatitis, Act Now,” which aims to enhance public awareness of hepatitis prevention and control, and encourage全社会 participation in reducing new infections and effectively identifying and treating patients.

Experts and representatives from various sectors, including clinical, public health, foundations, NGOs, and enterprises, gather to share their insights on the exploration and achievements in hepatitis prevention and control in China, and to call on the public and hepatitis patients to take action to create a future without hepatitis.

China is poised to eliminate hepatitis, driven by continuous policy and legislative efforts, updates to prevention guidelines, expedited approval of innovative drugs, advancements in diagnostic technologies, and public health education. Screening, a critical component of the eradication efforts, has been piloted in regions like Haikou Danya and Guangdong Jun’an Town, where “screening for all” strategies provide free vaccination services to uninfected individuals and treatment and health management for confirmed patients.

Early diagnosis is the foundation for standardized treatment. Professor Xie Qing, the head of the Department of Infectious Diseases at the Ruijin Hospital affiliated with Shanghai Jiao Tong University, emphasizes the importance of “diagnosis for all” following screening, using more sensitive methods to detect low viral load in hepatitis B patients, which expands the scope of treatment. The current treatment strategy for hepatitis B is a “total treatment” approach, aiming to reduce the risk of liver cirrhosis and hepatocellular carcinoma through timely treatment.

With the advent of direct-acting antiviral (DAA) drugs in the pan-genotypic era for hepatitis C, the majority of hepatitis C patients can achieve cure with three months of continuous medication. This development brings hope to hepatitis C patients, reducing the long-term impact of the disease.

In conclusion, the establishment of an integrated collaboration mechanism and multifaceted efforts to eliminate viral hepatitis in multiple Chinese regions reflect the country’s high regard and innovative practices in hepatitis prevention and control. Through collective efforts, China is making steady progress towards its goal of eliminating hepatitis, setting a model for global hepatitis prevention and control efforts.

【来源】http://www.chinanews.com/life/2024/07-27/10258639.shtml

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注